S100 calcium-binding protein A9 (S100a9), a proinflammatory protein, has been shown to be involved in the development of neuroinflammatory disorders and neurodegenerative diseases. Upregulation of S100a9 in the brain during acute brain injury has been proposed to be associated with acute neuroinflammation. However, it remains unclear whether eliminating S100a9 expression will show beneficial outcomes after traumatic brain injury (TBI). Using S100a9 knockout mice, this study has demonstrated that S100a9 deletion ameliorates post-TBI anxiety, improves TBI-impaired motor and cognitive function, reduces lesion size, prevents perilesional neuron loss and neurodegeneration, diminishes neuroinflammation and TBI-induced neurogenesis, and enhances perilesional expression of neuroplasticity protein. These findings suggest that S100a9 plays a detrimental role in TBI. Genetic deletion of S100a9 enhances neuroprotection and improves functional outcome after TBI. This study sheds light on the pathological involvement of S100a9 in TBI, which would provide a new therapeutic target to minimize TBI-induced brain damage.
Get full access to this article
View all access options for this article.
References
1.
TaylorC.A., BellJ.M., BreidingM.J., and XuL. (2017). Traumatic brain injury–related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013. MMWR Surveill. Summ. 66, 1–16.
2.
MaasA.I.R., StocchettiN., and BullockR. (2008). Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7, 728–741.
3.
ZacksJ.M., KurbyC.A., LandazabalC.S., KruegerF., and GrafmanJ. (2016). Effects of penetrating traumatic brain injury on event segmentation and memory. Cortex, 74, 233–246.
4.
FinoP.C., PeterkaR.J., HullarT.E., MurchisonC., HorakF.B., ChesnuttJ.C., and KingL.A. (2017). Assessment and rehabilitation of central sensory impairments for balance in mTBI using auditory biofeedback: a randomized clinical trial. BMC Neurol. 17, 41.
5.
JorgeR.E., AcionL., StarksteinS.E., and MagnottaV. (2007). Hippocampal volume and mood disorders after traumatic brain injury. Biol. Psychiatry, 62, 332–338.
6.
VeenithT., GoonS.S.H., and BurnsteinR.M. (2009). Molecular mechanisms of traumatic brain injury: the missing link in management. World J. Emerg. Surg. 4, 7.
7.
WernerC., and EngelhardK. (2007). Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99, 4–9.
8.
CorpsK.N., RothT.L., and McGavernD.B. (2015). Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 72, 355–362.
9.
ReedA.R., and WelshD.G. (2002). Secondary injury in traumatic brain injury patients—a prospective study. S. Afr. Med. J. 92, 221–224.
10.
HawrylukG.W.J., and BullockM.R. (2015). Design of acute neuroprotection studies, in: Handbook of Clinical Neurology. J. Grafman and A.M. Salazar (eds). Elsevier B.V.: Amsterdam, pps. 761–778.
11.
MarkowitzJ., and CarsonW.E. III. (2013). Review of S100A9 biology and its role in cancer. Biochim. Biophys. Acta, 1835, 100–109.
12.
GrudenM.A., DavydovaT.V., WangC., NarkevichV.B., FominaV.G., KudrinV.S., Morozova-RocheL.A., and SewellR.D. (2016). The misfolded pro-inflammatory protein S100A9 disrupts memory via neurochemical remodelling instigating an Alzheimer's disease-like cognitive deficit. Behav. Brain Res. 306, 106–116.
13.
BjorkP., BjorkA., VoglT., StenstromM., LibergD., OlssonA., RothJ., IvarsF., and LeandersonT. (2009). Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 7, e97.
14.
HorvathI., JiaX., JohanssonP., WangC., MoskalenkoR., SteinauA., ForsgrenL., WagbergT., SvenssonJ., ZetterbergH., and Morozova-RocheL.A. (2016). Pro-inflammatory S100A9 protein as a robust biomarker differentiating early stages of cognitive impairment in Alzheimer's disease. ACS Chem. Neurosci. 7, 34–39.
15.
RothJ., VoglT., SorgC., and SunderkotterC. (2003). Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155–158.
16.
ChangK.-A., HaT.-Y., KimJ., and SuhY.-H. (2009). The role of S100a9 in the neuroinflammation of Alzheimer's disease transgenic mouse model, Tg2576. Alzheimers Dement. 5, P481.
17.
HorvathI., IashchishynI.A., MoskalenkoR.A., WangC., WarmlanderS., WallinC., GraslundA., KovacsG.G., and Morozova-RocheL.A. (2018). Co-aggregation of pro-inflammatory S100A9 with alpha-synuclein in Parkinson's disease: ex vivo and in vitro studies. J. Neuroinflammation, 15, 172.
18.
DenstaedtS.J., Spencer-SegalJ.L., NewsteadM.W., LaborcK., ZhaoA.P., HjelmaasA., ZengX., AkilH., StandifordT.J., and SingerB.H. (2018). S100A8/A9 drives neuroinflammatory priming and protects against anxiety-like behavior after sepsis. J. Immunol. 200, 3188–3200.
19.
LassmannH. (1997). Basic mechanisms of brain inflammation. J. Neural Trans. Suppl. 50, 183–190.
20.
PostlerE., LehrA., SchluesenerH., and MeyermannR. (1997). Expression of the S-100 proteins MRP-8 and -14 in ischemic brain lesions. Glia, 19, 27–34.
21.
ZieglerG., PrinzV., AlbrechtM.W., HarhausenD., KhojastehU., NackenW., EndresM., DirnaglU., NietfeldW., and TrendelenburgG. (2009). Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia. Biochim. Biophys. Acta, 1792, 1198–1204.
22.
EngelS., SchluesenerH., MittelbronnM., SeidK., AdjodahD., WehnerH.D., and MeyermannR. (2000). Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol. 100, 313–322.
23.
WangC., KlechikovA.G., GharibyanA.L., WarmlanderS.K., JarvetJ., ZhaoL., JiaX., NarayanaV.K., ShankarS.K., OlofssonA., BrannstromT., MuY., GraslundA., and Morozova-RocheL.A. (2014). The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 127, 507–522.
24.
ManitzM.-P., HorstB., SeeligerS., StreyA., SkryabinB.V., GunzerM., FringsW., SchönlauF., RothJ., SorgC., and NackenW. (2003). Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 23, 1034–1043.
25.
VoglT., EisenblatterM., VollerT., ZenkerS., HermannS., van LentP., FaustA., GeyerC., PetersenB., RoebrockK., SchafersM., BremerC., and RothJ. (2014). Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat. Commun. 5, 4593.
26.
EharaA., and UedaS. (2009). Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences. Acta Histochem. Cytochem. 42, 171–179.
27.
FerreiraT.A., BlackmanA.V., OyrerJ., JayabalS., ChungA.J., WattA.J., SjostromP.J., and van MeyelD.J. (2014). Neuronal morphometry directly from bitmap images. Nat. Methods, 11, 982–984.
28.
SpampanatoJ., SullivanR.K., TurpinF.R., BartlettP.F., and SahP. (2012). Properties of doublecortin expressing neurons in the adult mouse dentate gyrus. PLoS One, 7, e41029.
29.
CarronS.F., AlwisD.S., and RajanR. (2016). Traumatic brain injury and neuronal functionality changes in sensory cortex. Front. Syst. Neurosci. 10, 47.
30.
WashingtonP.M., ForcelliP.A., WilkinsT., ZappleD.N., ParsadanianM., and BurnsM.P. (2012). The effect of injury severity on behavior: a phenotypic study of cognitive and emotional deficits after mild, moderate, and severe controlled cortical impact injury in mice. J. Neurotrauma, 29, 2283–2296.
31.
SeibenhenerM.L., and WootenM.C. (2015). Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J. Vis. Exp. (96), e52434.
32.
HammR.J., PikeB.R., O'DellD.M., LyethB.G., and JenkinsL.W. (1994). The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J. Neurotrauma, 11, 187–196.
33.
D'HoogeR., and De DeynP.P. (2001). Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev. 36, 60–90.
34.
BajwaN.M., HalaviS., HamerM., SempleB.D., Noble-HaeussleinL.J., BaghchechiM., HirotoA., HartmanR.E., and ObenausA. (2016). Mild concussion, but not moderate traumatic brain injury, is associated with long-term depression-like phenotype in mice. PLoS One, 11, e0146886.
35.
FadenA.I., and LoaneD.J. (2015). Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?. Neurotherapeutics, 12, 143–150.
36.
YipP.K., Carrillo-JimenezA., KingP., VilaltaA., NomuraK., ChauC.C., EgertonA.M., LiuZ.H., ShettyA.J., TremoledaJ.L., DaviesM., DeierborgT., PriestleyJ.V., BrownG.C., Michael-TitusA.T., VeneroJ.L., and BurguillosM.A. (2017). Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Sci. Rep. 7, 41689.
37.
HongJ., and JangS. (2010). Degeneration of cingulum and fornix in a patient with traumatic brain injury: diffuse tensor tractography study. J. Rehabil. Med. 42, 979–981.
38.
SmithD.H., and MeaneyD.F. (2000). Axonal damage in traumatic brain injury. Neuroscientist, 6, 483–495.
39.
CarmichaelS.T. (2006). Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann. Neurol. 59, 735–742.
40.
NudoR.J. (2013). Recovery after brain injury: mechanisms and principles. Front. Hum. Neurosci. 7, 887.
41.
UlfigN., NickelJ., and BohlJ. (1998). Monoclonal antibodies SMI 311 and SMI 312 as tools to investigate the maturation of nerve cells and axonal patterns in human fetal brain. Cell Tissue Res. 291, 433–443.
42.
RouttenbergA., CantallopsI., ZaffutoS., SerranoP., and NamgungU. (2000). Enhanced learning after genetic overexpression of a brain growth protein. Proc. Natl. Acad. Sci. U. S. A. 97, 7657–7662.
43.
BenowitzL.I., and RouttenbergA. (1997). GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20, 84–91.
44.
MavielT., DurkinT.P., MenzaghiF., and BontempiB. (2004). Sites of neocortical reorganization critical for remote spatial memory. Science, 305, 96–99.
45.
LerchJ.P., YiuA.P., Martinez-CanabalA., PekarT., BohbotV.D., FranklandP.W., HenkelmanR.M., JosselynS.A., and SledJ.G. (2011). Maze training in mice induces MRI-detectable brain shape changes specific to the type of learning. Neuroimage, 54, 2086–2095.
46.
DashP.K., MachS.A., and MooreA.N. (2001). Enhanced neurogenesis in the rodent hippocampus following traumatic brain injury. J. Neurosci. Res. 63, 313–319.
47.
YuT.S., ZhangG., LieblD.J., and KernieS.G. (2008). Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. J. Neurosci. 28, 12901–12912.
48.
SunD., DanielsT.E., RolfeA., WatersM., and HammR. (2015). Inhibition of injury-induced cell proliferation in the dentate gyrus of the hippocampus impairs spontaneous cognitive recovery after traumatic brain injury. J. Neurotrauma, 32, 495–505.
49.
LeeA.S. (2017). Altered hippocampal neurogenesis during the first 7 days after a fluid percussion traumatic brain injury. Cell Transplant. 26, 1314–1318.
50.
WangX., GaoX., MichalskiS., ZhaoS., and ChenJ. (2016). Traumatic brain injury severity affects neurogenesis in adult mouse hippocampus. J. Neurotrauma, 33, 721–733.
51.
SunD. (2014). The potential of endogenous neurogenesis for brain repair and regeneration following traumatic brain injury. Neural Regen. Res. 9, 688–692.
52.
ScholtenA.C., HaagsmaJ.A., CnossenM.C., OlffM., van BeeckE.F., and PolinderS. (2016). Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury: a systematic review. J. Neurotrauma, 33, 1969–1994.
53.
TuckerL.B., FuA.H., and McCabeJ.T. (2016). Performance of male and female C57BL/6J mice on motor and cognitive tasks commonly used in pre-clinical traumatic brain injury research. J. Neurotrauma, 33, 880–894.
54.
PullelaR., RaberJ., PfankuchT., FerrieroD.M., ClausC.P., KohS.E., YamauchiT., RolaR., FikeJ.R., and Noble-HaeussleinL.J. (2006). Traumatic injury to the immature brain results in progressive neuronal loss, hyperactivity and delayed cognitive impairments. Dev. Neurosci. 28, 396–409.
55.
KimH.J., ChangK.A., HaT.Y., KimJ., HaS., ShinK.Y., MoonC., NackenW., KimH.S., and SuhY.H. (2014). S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS One, 9, e88924.
56.
HaT.Y., ChangK.A., KimJ., KimH.S., KimS., ChongY.H., and SuhY.H. (2010). S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS One, 5, e8840.
57.
VoglT., GharibyanA.L., and Morozova-RocheL.A. (2012). Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int. J. Mol. Sci. 13, 2893–2917.
58.
FoellD., and RothJ. (2004). Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50, 3762–3771.
59.
JohnsonV.E., StewartJ.E., BegbieF.D., TrojanowskiJ.Q., SmithD.H., and StewartW. (2013). Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain, 136, 28–42.
60.
HanellA., HedinJ., ClausenF., and MarklundN. (2012). Facilitated assessment of tissue loss following traumatic brain injury. Front. Neurol, 3, 29.
61.
WeidnerN., NerA., SalimiN., and TuszynskiM.H. (2001). Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc. Natl. Acad. Sci. U. S. A. 98, 3513–3518.
62.
WielochT., and NikolichK. (2006). Mechanisms of neural plasticity following brain injury. Curr. Opin. Neurobiol. 16, 258–264.
63.
BareyreF.M., KerschensteinerM., RaineteauO., MettenleiterT.C., WeinmannO., and SchwabM.E. (2004). The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat. Neurosci. 7, 269–277.
64.
FrostS.B., BarbayS., FrielK.M., PlautzE.J., and NudoR.J. (2003). Reorganization of remote cortical regions after ischemic brain injury: a potential substrate for stroke recovery. J. Neurophysiol. 89, 3205–3214.
65.
ShoichetM.S., TateC.C., BaumannM.D., and LaPlacaM.C. (2008). Strategies for regeneration and repair in the injured central nervous system, in: Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. W.M. Reichert (ed). CRC Press/Taylor & Francis: Boca Raton,FL.
ZhengW., ZhuGeQ., ZhongM., ChenG., ShaoB., WangH., MaoX., XieL., and JinK. (2013). Neurogenesis in adult human brain after traumatic brain injury. J. Neurotrauma, 30, 1872–1880.
68.
VillasanaL.E., KimK.N., WestbrookG.L., and SchnellE. (2015). Functional integration of adult-born hippocampal neurons after traumatic brain injury.eNeuro 2. pii: ENEURO.0056-15.2015. doi: 10.1523/ENEURO.0056-15.2015. eCollection 2015. Sep.
69.
HobbsJ.A., MayR., TanousisK., McNeillE., MathiesM., GebhardtC., HendersonR., RobinsonM.J., and HoggN. (2003). Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell. Biol. 23, 2564–2576.
70.
HessianP.A., EdgeworthJ., and HoggN. (1993). MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukocyte Biol. 53, 197–204.
RyckmanC., VandalK., RouleauP., TalbotM., and TessierP.A. (2003). Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170, 3233–3242.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
